PRICE T ROWE ASSOCIATES INC /MD/ - AMNEAL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$313
+40.4%
74,169
+3.3%
0.00%
Q2 2023$223
+696.4%
71,808
+262.3%
0.00%
Q1 2023$28
-20.0%
19,819
+12.5%
0.00%
Q4 2022$35
-99.9%
17,616
+3.1%
0.00%
Q3 2022$35,000
-99.9%
17,091
-99.8%
0.00%
-100.0%
Q3 2019$32,722,000
-75.6%
11,283,585
-39.6%
0.01%
-73.7%
Q2 2019$133,836,000
-52.4%
18,666,125
-6.0%
0.02%
-53.7%
Q1 2019$281,436,000
+6.0%
19,861,418
+1.2%
0.04%
-8.9%
Q4 2018$265,482,000
+8.1%
19,621,696
+77.2%
0.04%
+25.0%
Q3 2018$245,654,000
+34402.0%
11,070,504
+25401.0%
0.04%
Q2 2018$712,00043,4120.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders